THERAPEUTIC VITRECTOMY AS AN ADJUNCT TREATMENT TO SYSTEMIC CHEMOTHERAPY FOR INTRAOCULAR LYMPHOMA
| Autor: | Dan J. Kim, Bertil Damato, Armin R. Afshar, Gregory J. Bever, James L. Rubenstein |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty Lymphoma genetic structures medicine.medical_treatment Antineoplastic Agents Vitrectomy Article 03 medical and health sciences Rare Diseases 0302 clinical medicine Intraocular Lymphoma Opthalmology and Optometry medicine Chemotherapy Humans Eye Disease and Disorders of Vision Adjuvant Cancer medicine.diagnostic_test Systemic chemotherapy business.industry Magnetic resonance imaging Hematology General Medicine Middle Aged medicine.disease Magnetic Resonance Imaging eye diseases Surgery Ophthalmology Left eye Treatment Outcome Chemotherapy Adjuvant 030220 oncology & carcinogenesis 030221 ophthalmology & optometry sense organs Intraocular lymphoma business Vitreoretinal lymphoma |
| Zdroj: | Retin Cases Brief Rep Retinal cases & brief reports, vol 14, iss 2 |
| ISSN: | 1935-1089 |
| DOI: | 10.1097/icb.0000000000000668 |
| Popis: | Purpose: To report the outcome of a previously vitrectomized eye having less lymphoma disease burden compared with the contralateral nonvitrectomized eye over the course of 3.5 years while on systemic chemotherapy. Methods: Case report. Results: A 51-year-old man with vitreoretinal lymphoma with central nervous system involvement underwent vitrectomy in his left eye. Over the following 3.5 years on systemic chemotherapy, the left eye had less lymphoma disease burden compared with the contralateral nonvitrectomized right eye. Conclusion: Therapeutic vitrectomy may be a useful adjunct to systemic chemotherapy in vitreoretinal lymphoma, particularly in cases of vitreous predominant disease manifestation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|